Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1995-3-29
pubmed:abstractText
The "outside-in" signals produced by the interaction of integrin molecules with the extracellular matrix (ECM) trigger a multitude of cellular events. The vitronectin receptor (VNR), an alpha v beta 3 heterodimer, functions as a costimulatory molecule for the activation of a subset of V gamma 1.1/C gamma 4-bearing gamma/delta T cells, which have been postulated to recognize a ubiquitous self-antigen. We addressed the question of whether stimulation of these T cells requires both engagement of the VNR by ECM proteins and engagement of the TCR by its Ag. We introduced into a TCR- but VNR+ mutant T cell hybridoma, TG40 (derived from 2B4), a chimeric molecule that contains the cytoplasmic tail of the TCR zeta-chain fused to the cytoplasmic and transmembrane region of either human CD8 or human CD25. The transfectants expressing the chimeric molecules secreted IL-2 constitutively when the VNR was engaged with a ligand, e.g., provided by ECM proteins present in FCS. This constitutive cytokine secretion could be blocked with mAb directed against the VNR, with or the peptide RGD, or by growth in serum-free medium. VNR-mediated cell activation also induced the phosphorylation of the zeta-chain. Signaling through the zeta-chain was required, as cells transfected with a chimera containing only a 22 amino-acid long, truncated zeta-chain did not secrete IL-2 constitutively. Thus, we demonstrated that the binding of the VNR to ECM protein in the presence of the zeta-chain is sufficient to induce cytokine secretion by T cells and does not require the recognition of an Ag by the TCR. Such integrin-mediated, Ag-independent activation of T cells may play a critical role in the potentiation of inflammatory responses.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-1767
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
154
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2104-11
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:7532660-Animals, pubmed-meshheading:7532660-Antigens, pubmed-meshheading:7532660-Cytokines, pubmed-meshheading:7532660-Extracellular Matrix Proteins, pubmed-meshheading:7532660-Humans, pubmed-meshheading:7532660-Hybridomas, pubmed-meshheading:7532660-Integrins, pubmed-meshheading:7532660-Lymphocyte Activation, pubmed-meshheading:7532660-Mice, pubmed-meshheading:7532660-Models, Biological, pubmed-meshheading:7532660-Phosphorylation, pubmed-meshheading:7532660-Receptors, Antigen, T-Cell, gamma-delta, pubmed-meshheading:7532660-Receptors, Cytoadhesin, pubmed-meshheading:7532660-Receptors, Vitronectin, pubmed-meshheading:7532660-Signal Transduction, pubmed-meshheading:7532660-T-Lymphocyte Subsets, pubmed-meshheading:7532660-T-Lymphocytes, pubmed-meshheading:7532660-Transfection
pubmed:year
1995
pubmed:articleTitle
Antigen-independent, integrin-mediated T cell activation.
pubmed:affiliation
Laboratory of Molecular Structure, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
pubmed:publicationType
Journal Article